Champions Oncology Inc (CSBR)

[fred the cpa]

It is my opinion that CSBR has reached the conclusion that the development of cancer curing drugs and the further testing and marketing of these drugs on a joint venture basis is simply too expensive. So, except for the drug that they currently have, they are no longer going to in- licenese any more possible cancer curing drugs but instead they will receive a minority interest in a Company yet to be foremd in which they will send to that Company drugs that show promise for possibly helping to cure certain cancers. It is possible that they will joint venture with the Company or possibly receive a royalty from the new company as well as hold a minority interest in the new company. In this way they could avoid the huge expense in the licensing and developing of new drugs while, at the same time, obtain a financial interest through a minority interest in the new company. All of this still remains to be worked out and i feel it is simply too early to reach any conclusions as to the effect that this will have on CSBR on a cumulative basis when all things are considered. I believe that CSBR remains a strong investment ooportunity.